Oragenics Inc (OGEN)
1.02
-0.01
(-0.97%)
USD |
NYAM |
Apr 29, 15:39
Oragenics Cash from Operations (TTM): -7.291M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -7.291M |
September 30, 2023 | -8.621M |
June 30, 2023 | -10.89M |
March 31, 2023 | -11.70M |
December 31, 2022 | -15.23M |
September 30, 2022 | -14.68M |
June 30, 2022 | -16.08M |
March 31, 2022 | -14.78M |
December 31, 2021 | -13.47M |
September 30, 2021 | -15.22M |
June 30, 2021 | -14.70M |
March 31, 2021 | -17.46M |
December 31, 2020 | -16.95M |
September 30, 2020 | -17.26M |
June 30, 2020 | -15.97M |
Date | Value |
---|---|
March 31, 2020 | -14.62M |
December 31, 2019 | -13.01M |
September 30, 2019 | -12.05M |
June 30, 2019 | -11.13M |
March 31, 2019 | -9.924M |
December 31, 2018 | -9.080M |
September 30, 2018 | -7.461M |
June 30, 2018 | -6.346M |
March 31, 2018 | -5.83M |
December 31, 2017 | -6.364M |
September 30, 2017 | -6.969M |
June 30, 2017 | -7.302M |
March 31, 2017 | -7.294M |
December 31, 2016 | -7.075M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-17.46M
Minimum
Mar 2021
-7.291M
Maximum
Dec 2023
-13.74M
Average
-14.68M
Median
Sep 2022
Cash from Operations (TTM) Benchmarks
Palatin Technologies Inc | -26.54M |
Inogen Inc | -3.234M |
Cyclacel Pharmaceuticals Inc | -16.11M |
Actinium Pharmaceuticals Inc | -47.34M |
MAIA Biotechnology Inc | -13.07M |